stockportfolio.pro
Stocks / OCGN vs OVID
OCGN vs OVID
Ocugen, Inc. and Ovid Therapeutics Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Ocugen, Inc. (OCGN) | Ovid Therapeutics Inc. (OVID) | |
|---|---|---|
| Market cap | $0.4B | $0.4B |
| Revenue (latest FY) | $4.41M | $7.25M |
| Net income (latest FY) | $-67.85M | $-17.41M |
| Revenue growth (5y CAGR) | 152.5% | -10.5% |
| Net margin | -1537.4% | -240.1% |
| Return on equity | 557.7% | -13.3% |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 0 | 1 |
| Positive free cash flow | No | No |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open OCGN — free Open OVID — freeFrequently asked questions
Which is bigger, OCGN or OVID?
Ovid Therapeutics Inc. is larger by market capitalization — $0.4B versus $0.4B.
Which grows faster, OCGN or OVID?
Over the last five fiscal years, Ocugen, Inc. grew revenue faster — 152.5%/yr versus -10.5%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.